Germline mutations of APC in patients with Turcot syndrome (colon cancer and medulloblastoma), was well as somatic mutations of APC, b-catenin, and Axin in sporadic medulloblastomas (MBs) have shown the importance of WNT signaling in the pathogenesis of MB. A subset of children with MB have germline mutations of SUFU, a known inhibitor of Hedgehog signal transduction. A recent report suggested that murine Sufu can bind b-catenin, export it from the nucleus, and thereby repress b-catenin/T-cell factor (Tcf)-mediated transcription. We show that an MB-derived mutant of SUFU has lost the ability to decrease nuclear levels of b-catenin, and cannot inhibit b-catenin/Tcf-mediated transcription as compared to wild type SUFU. Our results suggest that loss of function of SUFU results in overactivity of both the Sonic Hedgehog, and the WNT signaling pathways, leading to excessive proliferation and failure to differentiate resulting in MB.
Introduction
Brain tumors are the most common solid tumor in children. The most common malignant pediatric brain tumor is the medulloblastoma (MB) . MBs are thought to arise from neoplastic transformation of cells in the external granule cell layer of the developing cerebellum (Wechsler-Reya and Scott, 1999; Wechsler-Reya, 2003) . Much of what is known about the molecular pathogenesis of MB has been discovered through the study of familial tumor syndromes, including nevoid basal cell carcinoma syndrome (Gorlin syndrome), Turcot syndrome, and Li-Fraumeni syndrome .
We recently reported that a subset of children with the desmoplastic variant of MB harbor truncating germline mutations, or deletions of the Human Suppressor of Fused (SUFU) gene (Taylor et al., 2002) . Tumors from these children showed loss of heterozygosity, implying that SUFU is a bona fide tumor suppressor gene, and that germline mutation of SUFU is a novel mechanism predisposing to MB. SUFU is a known inhibitor of the Sonic Hedgehog (SHH) signaling cascade; it is thought to repress SHH signaling by exporting the effectors of SHH signaling, the Gli family of transcription factors from the nucleus to the cytoplasm where they are inactive (Ding et al., 1999; Pearse et al., 1999; Methot and Basler, 2000; Murone et al., 2000) . An MB-derived truncated mutant of SUFU was shown to have lost its association with Gli1, and lost the ability to export Gli1 from the nucleus and therefore repress SHH signaling (Taylor et al., 2002) .
Turcot syndrome is diagnosed in patients who have both colonic and CNS neoplasms. This syndrome can be divided into two different diseases that are clinically and molecularly distinct. One subset includes patients with germline mutations in DNA mismatch repair proteins (i.e., hMLH1, hMSH2, hPMS2); these patients develop a few colonic polyps, are predisposed to colonic adenocarcinoma, and may develop gliomas of the CNS (Hamilton et al., 1995; Taylor et al., 1999) . Another subset of individuals with germline mutations of the tumor suppressor gene APC on chromosome 5q21 are prone to familial adenomatosis polypi (FAP), and develop thousands of polyps in their colon, many of which may progress to colorectal cancer. Individuals with germline APC mutations are also at increased risk of developing MB. The wild-type APC allele in MB has been reported to be lost in patients with Turcot syndrome suggesting that APC functions as a tumor suppressor gene in the cerebellum (Hamilton et al., 1995; Steigerwald et al., 2001) . The relative risk of developing a brain tumor is increased by a factor of 23 in family members of patients with germline APC mutations, and the relative risk of developing a cerebellar MB was 92 (Po0.001) (Hamilton et al., 1995) . There appears to be familial clustering of brain tumors among patients with germline APC mutations (Hamilton et al., 1995) .
The importance of the APC gene in the pathogenesis of sporadic MB is less clear. Reports in the literature concerning APC mutations have been confusing as different techniques have been used to evaluate the integrity of the APC locus. In two reports, totaling 49 patients, there was no loss of heterozygosity at the APC allele (Yong et al., 1995; Vortmeyer et al., 1999) . Another report failed to reveal any somatic mutations in 49 MBs regardless of whether or not MB was associated with Turcot syndrome (Mori et al., 1994) . Two groups have found missense mutations of APC in the 4/143 tumors analysed, but there was no loss of the wild-type allele (Huang et al., 2000; Koch et al., 2001) . One of the germline mutations found was the E1317Q 'subpolymorphic' variant that has been described in association with a predisposition to colorectal tumors as it was found in 4/164 patients with multiple colorectal tumors but not in 160 control alleles (Frayling et al., 1998) . Why patients with germline mutations in the APC gene develop MBs at an increased rate, and yet somatic APC mutations are seldom if ever found in sporadic MBs is unknown. Unlike colorectal carcinoma where the APC mutations are truncating, those found in MB are missense mutations and due to the large nature of the APC gene, it is conceivable that some of these mutations in sporadic MB may have been missed. Recently, two separate groups have identified a brainspecific homologue of APC, called either APCL or APC2 on chromosome 19p13.3 that appears to play a homologous role in WNT signaling to APC (Nakagawa et al., 1999; van Es et al., 1999) . Mutational analysis of APCL in a series of five MBs did not reveal any mutations (Nakagawa et al., 1999) . As APC2 is not expressed in the colonic epithelium, inactivation of both APC alleles in the colon could be predicted to result in overactive WNT signaling. Conversely, in the CNS where APC2 is expressed, loss of both APC alleles still leaves both APC2 alleles that may be able to compensate for the loss of APC functionally.
Loss of APC function allows the WNT effector, bcatenin to escape from ubiquitin-mediated degradation. This results in transcriptional activation of the WNT signaling pathway, which also plays important roles in development. Some colon cancers without APC mutations have missense mutations in N-terminus residues of b-catenin that are normally phosphorylated by GSK-3b making the mutant b-catenin resistant to ubiquitination and proteasome degradation. (Rubinfeld et al., 1997; Iwao et al., 1998) . In these tumors, b-catenin is postulated to act as an oncogene. MBs have also been shown to harbor these types of missense mutations in bcatenin (Zurawel et al., 1998; Eberhart et al., 2000; Huang et al., 2000) . Both active WNT signaling and activating mutations of b-catenin can result in the accumulation of nuclear b-catenin. Nuclear b-catenin has been noted in up to 18% of MB suggesting WNT overactivity (Eberhart et al., 2000) . b-catenin mutations have been described in both classical and desmoplastic MBs. In one report, an MB tumor had b-catenin and PTCH mutations suggesting that overactivity of both the SHH and WNT signaling pathways can occur in MB (Vortmeyer et al., 1999; Koch et al., 2001) . On the other hand, Koch et al. (2001) found that mutations of APC and b-catenin were mutually exclusive in MB. Mutational analysis of GSK-3b and b-TRCP did not reveal any mutations in a series of MBs even though both are negative regulators of WNT signaling (Zurawel et al., 1998; Taylor et al., 2002) . Both deletions and missense mutations have been reported in the WNT pathway inhibitor AXIN (Dahmen et al., 2001; Yokota et al., 2002; Baeza et al., 2003) . Taken together, there is good evidence that overactivity of the WNT signaling pathway is involved in the pathogenesis of at least some MBs.
In the absence of WNT signaling, b-catenin is phosphorylated and degraded through the ubiquitin proteasome pathway, mediated by b-TRCP (Hart et al., 1998 (Hart et al., , 1999 Kitagawa et al., 1999; Latres et al., 1999; Winston et al., 1999) . Stimulation of the WNT pathway results in the accumulation of b-catenin and its translocation to the nucleus where it binds the T-cell factor (Tcf) family of transcription factors activating transcription of downstream targets such as MYC and Cyclin D1 (Frayling et al., 1998; Shtutman et al., 1999) .
It was recently reported that the murine homologue of Sufu bound to b-catenin, exported it from the nucleus, and repressed b-catenin/Tcf-mediated transcriptional activation (Meng et al., 2001 ). SW480 cells have excessive WNT signaling due to a complete loss of APC; overexpression of Sufu in this cell line resulted in decreased growth in nude mice, suggesting that Sufu can act as a tumor suppressor gene (Meng et al., 2001) . This suggestion that SUFU might function in the WNT signaling pathway, as well as the SHH pathway led us to hypothesize that loss of SUFU function in cerebellar granule cells might activate both pathways, contributing to the pathogenesis of MB (Figure 1 ).
Results
Both full-length SUFU and an MB-derived mutant: SUFU-Dex8 are found in a complex with endogenous b-catenin
The SW480 cell line has no functional APC and, therefore, has high levels of endogenous b-catenin. We hypothesized that the Dex8 mutant of SUFU (cloned from the desmoplastic MB of a child with a large deletion on chromosome 10q that encompasses SUFU) might fail to bind endogenous b-catenin, and thereby fail to suppress Tcf-dependent transcription. As shown in Figure 2 , transfected myc-tagged wild type, and the Dex8 of mutant SUFU can both bind endogenous bcatenin in 293 cells, whereas the amino-terminal mutant of SUFU, SUFU-D-212 mutant, cannot. This demonstrates, that similar to the mouse Sufu protein, human SUFU is found in a protein complex with the WNT pathway effector b-catenin, and that the association persists with the MB-derived mutant SUFU-Dex8.
Wild-type SUFU, but not the MB-derived mutant SUFU-Dex8 can decrease the level of endogenous nuclear b-catenin High levels of nuclear b-catenin are thought to reflect activation of the WNT signaling pathway. SW480 cells have no functioning APC protein and therefore have elevated levels of WNT signaling with abundant nuclear b-catenin. Fluorescence microscopy of SW480 cells transfected with either wild type, or Dex8 mutant SUFU reveals that while abundant nuclear b-catenin is present in untransfected cells, or cells transfected with the Dex8 mutant, cells transfected with the wild-type construct possess considerably less nuclear b-catenin (Figure 3) . In SW480 cells that have high levels of Tcf-mediated signaling, wild-type SUFU is largely cytoplasmic, as opposed to SUFU-Dex8, which is mostly found in the nucleus. Leptomycin B is a specific inhibitor of CRM-1-mediated nuclear export. Leptomycin B can inhibit the effects of SUFU-WT, resulting in large nuclear accumulation of b-catenin (Figure 2 ) but has no effect on SUFU-Dex8 transfectants where there are already large amounts of nuclear b-catenin (Figure 3 ). This demonstrates that whereas wild-type SUFU expression results in a diminution in the level of nuclear b-catenin, the tumor-derived mutant SUFU-Dex8 does not, despite the fact that it maintains its association in a protein complex with b-catenin. (Figure 4) . Conversely, SUFU-Dex8 was unable to reduce the expression of nuclear b-catenin in the same assay (Figure 4) .
Similarly, transfection of SW480 cells with empty vector, SUFU-WT, or SUFU-Dex8 followed by selection in media containing G418 for 2 weeks, shows that in the SW480 cell line, expression of SUFU-WT results in a 29% decrease in the expression of endogenous nuclear b-catenin as compared to empty vector control. SUFU-Dex8 was again unable to reduce the expression of endogenous nuclear b-catenin (data not shown). These findings support our hypothesis that loss of function of SUFU leads to nuclear accumulation of bcatenin, and increased activity of the canonical WNT pathway through increased b-catenin/Tcf-dependent transcription.
SUFU-WT, but not the Dex8 mutant can repress TCFdependant transcription
The luciferase reporter vector pTOPFLASH contains several Tcf-binding sites upstream from a minimal basal promotor. pFOPFLASH is similar, but the Tcf-binding sites are mutated so that they will not bind Tcf. We transfected 293 cells with either empty vector, SUFU-WT, or SUFU-Dex8 as well as pTOPFLASH and a b-galactosidase (b-Gal) expression vector. Transfection efficiencies were monitored by measurement of b-Gal activity. Measurement of TCF-dependant transcriptional activation using pTOPFLASH demonstrated a significant suppression of luciferase activity with wild-type SUFU as compared to empty vector, but no suppression was seen with SUFU-Dex8 ( Figure 5 ). There was no difference in luciferase activities between SUFU-WT and SUFU-Dex8 when pFOPFLASH was used (data not shown). Together, these results indicate that wild type but not the truncated Dex8 mutant SUFU can repress Tcf-dependent transcription, the final common mediator of the canonical WNT signaling pathway.
Discussion
Germline mutations of APC in patients with Turcot syndrome, and somatic mutations of APC, b-catenin, and AXIN in MBs provide molecular genetic evidence that activation of the WNT signaling pathway is important in the pathogenesis of both familial and sporadic MB. This concept is also biologically appealing as WNT signaling is known to have a strong mitogenic effect in the developing nervous system as has been demonstrated in transgenic mice (Dickinson et al., 1994) . Inhibition of the negative WNT regulator GSK3b by lithium chloride can stimulate granule cell proliferation, although recent evidence suggests that GSK-3b also negatively regulates the SHH pathway (Cui et al., 1998; Jia et al., 2002 ; Price and Kalderon, Figure 3 SW480 cells were transfected with either SUFU-wt-Myc or SUFU-Dex8-Myc, and stained with primary antibodies against the Myc epitope (rabbit polyclonal) and b-catenin (mouse monoclonal) followed by staining with rhodamine-anti-rabbit and FITC anti-mouse secondary antibodies. Cells were also stained with DAPI for nuclear localization. Fluorescence microscopy reveals that cells transfected with SUFU-wt have greatly diminished nuclear b-catenin compared to untransfected cells and cells transfected with SUFU-Dex8. Leptomycin B is able to block the effects of SUFU-wt transfection resulting in high levels of nuclear b-catenin but as expected has no effect on the SUFU-Dex8 transfectants where b-catenin is already nuclear 2002). The importance of WNT signaling is further demonstrated by Wnt-1(À/À) mutant mice that have almost no cerebellum (Thomas et al., 1991) .
WNT signaling shares a number of proteins with HH signaling including b-TRCP, CBP, GSK-3b, Casein Kinase 1, Dally-like protein, and SUFU (Jiang and Struhl, 1998; Maniatis, 1999; Winston et al., 1999; Takemaru and Moon, 2000; Meng et al., 2001; Jia et al., 2002; Kalderon, 2002; Price and Kalderon, 2002; Lum et al., 2003) . Significantly, individuals with germline mutations of CBP (Rubinstein-Taybi syndrome) are at increased risk of developing MB (Evans et al., 1993; Miller and Rubinstein, 1995; Skousen et al., 1996; Taylor et al., 2001) . There is a complex functional relationship between HH and WNT signaling. In some developmental circumstances HH signaling has been shown to induce WNT signaling (Mullor et al., 2001; Reddy et al., 2001) , while in others it competes with WNT signaling to decide cell fates (Lee et al., 2000) . Other authors have reported that WNT signaling is important in the regulation of Gli transcription factors, the effectors of HH signaling (Borycki et al., 2000) .
While wild-type SUFU is found in a protein complex with the SHH effector Gli1, this protein interaction is lost with the MB-derived mutant SUFU-Dex8 (Taylor et al., 2002) . SUFU-Dex8 has lost the ability to suppress Gli1-mediated transcription as it cannot bind Gli1. In contradistinction, SUFU-Dex8 maintains its association with b-catenin, yet it is unable to repress b-catenin/Tcfmediated transcription. As shown in Figure 3 , the mutant form of SUFU accumulates in the nucleus, as opposed to wild-type SUFU that is largely cytoplasmic. One hypothesis is that the carboxy terminus of SUFU is necessary for its association with the nuclear export machinery. SUFU has also been reported to bind to b-TRCP, an E3 ubiquitin ligase known to participate in the degradation of both Gli transcription factors, and bcatenin (Maniatis, 1999; Stone et al., 1999) . While SUFU-Dex8 is able to bind to b-catenin, it is unable to export it from the nucleus to the cytoplasm, where the known association between SUFU and b-TRCP may lead to its degradation by the proteasome. Eberhart et al. (2000) found nuclear b-catenin by immunohistochemistry in 9/51 MB (18%) suggesting that WNT signaling is overactive in about one-fifth of sporadic MB. Sequencing of six of the tumors with nuclear staining for b-catenin revealed four cases with activating mutations of b-catenin. Mutations in genes regulating b-catenin export and degradation, such as SUFU, may explain the nuclear accumulation in the cases lacking genetic alterations in b-catenin. As such, we are planning to utilize an MB tissue microarray to examine the b-catenin immunohistochemical localization. Specimens that demonstrate high levels of nuclear b-catenin will have both SUFU and b-catenin sequenced looking for mutations that could explain the increased nuclear staining. These authors also found nuclear bcatenin in cells of the differentiated, postmitotic adult internal granular cell layer of the cerebellum but not in the mitotic external granular cell layer of the fetal cerebellum, calling into question the relevance of nuclear staining for b-catenin (Eberhart et al., 2000) .
We selected the SUFU-Dex8 mutant for biochemical analysis and have demonstrated that it disrupts the SHH Figure 4 SUFU-WT but not SUFU-Dex8 decreases nuclear bcatenin. The 293 cells were transfected with either empty vector (pcDNA 3.1( þ ), SUFU-wt-Myc, or SUFU-Dex8-Myc. After 48 h nuclear and cytoplasmic lysates were prepared followed by PAGE and Western blotting. The ECL activity was quantitated in real time on a cooled CCD camera and FluorChem software to assure that all values remained in the linear range. The level of b-catenin was normalized to the expression level of PARP. Expression of SUFU-wt resulted in a 31% decrease in the level of nuclear bcatenin whereas expression of SUFU-Dex8 failed to decrease the level of nuclear b-catenin as compared to empty vector. PARP (nuclear protein) and Caspase-3 (cytoplasmic protein) Western blots show excellent fractionation and an anti-myc blot shows equal expression of SUFU-wt and SUFU-Dex8. C ¼ cytoplasmic fraction. N ¼ nuclear fraction Figure 5 SUFU-wt but not SUFU-Dex8 can suppress TCFdependent transcription. Transfection of SUFU-wt can inhibit transcription from a TCF-responsive promotor construct (TOP-FLASH) as compared to empty vector. Transfection of SUFUDex8 has no effect on TCF-dependent transcription. Neither SUFU-wt nor SUFU-Dex8 had any effect on transcription from the same reporter construct in which the TCF-binding sites were mutated (FOPFLASH, data not shown) and the WNT signaling pathways through failure to suppress two very important oncogenes, Gli1 and bcatenin. Both of these proteins have established roles in the pathogenesis of MB, and thus the biological rationale for SUFU as an MB predisposition gene is very strong (Figure 1 ). Our data suggest that failure to regulate both HH and WNT signaling properly in granule cell precursors secondary to the loss of SUFU leads to excessive proliferation and loss of differentiation of cerebellar precursor cells resulting in the formation of MB.
Materials and methods

Co-precipitation assay
The 293 cells were transfected with either pcDNA 3.1( þ ) empty vector, pcDNA 3.1( þ )-MYC-SUFU-wt, pcDNA 3.1( þ )-MYC-SUFU-Dex8, pcDNA 3.1( þ )-MYC-SUFU-(212-484) (Taylor et al., 2002) , or pcDNA3-MYC-SCYTHE (a kind gift of S Kornbluth). Cells were lysed in 500 ml of lysis buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1 mM EDTA). Lysates were incubated overnight at 41C with 2 ml of anti-myc monoclonal antibody (UBI), or 1 ml of a monoclonal anti-b-catenin antibody (BD Transduction Laboratory), and 50 ml of 20% protein G Sepharose beads (Sigma). Beads were washed five times in IP washing buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 100 mM ZnCl 2 , 2 mM EDTA, 1% NP-40 and 10% glycerol), resuspended in Laemmli sample buffer and boiled. Samples were separated by SDS-PAGE (immunoprecipitate: lysate in a 50 : 1 ratio), transferred to polyvinylidene difluoride membranes (Immobilon P), probed with an anti-Myc monoclonal antibody (UBI), or a monoclonal anti-b-catenin antibody (BD Transduction Laboratory), and developed using enhanced chemiluminescence.
Immunofluorescence SW480 cells were grown on glass coverslips, and then transfected with plasmid DNA using Fugene 6 (Roche) according to the manufacturer's instructions. Some coverslipmounted cells were grown in the presence of the nuclear export inhibitor leptomycin B. Cells were fixed in 371C 4% paraformaldehyde for 10 min and permeabilized by incubation in methanol for 2 min. Cells were incubated in blocking solution (PBS with 10% goat serum) for 1 h at room temperature (RT) and then incubated for 1 h at RT with primary antibodies (rabbit anti-MYC antibody (Santa Cruz) to detect transfected SUFU and its mutants, or endogenous bcatenin was detected by monoclonal anti-b-catenin antibody (BD Transduction Laboratory). Cells were incubated overnight at 41C with secondary antibodies (FITC labeled Goat Anti-Mouse IgG and Rhodamine labeled Goat anti-rabbit). Nuclei were counterstained with DAPI. Fluorescence images were obtained using a Leica DMIRE2 inverted fluorescent microscope using Open Lab software (Improvision).
Promotor assay
The 293 cells plated in 35 mm dishes were transiently transfected in triplicate with 1000 ng of the luciferase reporter construct pTOPFLASH or pFOPFLASH for 36 h before measuring TCF transcriptional activation. Fugene 6 (Roche) transfection reagent was utilized according to the manufacturer's instructions, and in all cases, pCMV-b-Gal was also transfected as a control for transfection efficiency. Cells were harvested 36 h after the transfection, and luciferase reporter enzyme activity was measured using a luminometer, and normalized to b-Gal. The pTOPFLASH reporter construct contains the consensus binding sequence for TCF transcription factors linked to a luciferase reporter and the pFOPFLASH reporter construct contains a mutated binding sequence linked to the reporter as a control. Each experiment was independently repeated three times. Means and standard deviations were determined for each cell type and transfection condition.
Nucleocytoplasmic Westerns
The 293 cells were transfected with Polyfect (Quiagen) and lysed 48 h later in Buffer A (10 mM HEPES-KOH pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, and Complete Protease inhibitors (Roche)) followed by a 10 min incubation on ice. An amount of 25 ml of ice-cold 10% NP-40 was added followed by brief mixing by vortex. The supernatant was kept as the cytoplasmic lysate, the pellet was washed once in Buffer A. The pellet was lysed in Buffer C (20 mM HEPES-KOH pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA and protease inhibitors), centrifuged briefly with the supernatant kept as the nuclear fraction. Equal amounts of lysate were separated by PAGE and analysed by immunoblotting for b-catenin (BDI Transduction Laboratories), following which the membrane was stripped and probed with polyclonal anti-PARP antibodies (UBI). Immunoblots for myc (monoclonal, UBI) and caspase 3 (polyclonal, Santa Cruz) were also performed. The ECL activity was quantified in real time using a cooled CCD camera and FluorChem Software (Packard) to insure that expression data were within the linear range. The b-catenin/ PARP expression ratio was determined for each sample. This experiment was independently repeated two additional times.
